Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitals

American Journal of Infection Control

Volumn 44, Issue 5, 2016, Pages 548-553

  Yi, Sarah H ^a   Jernigan, John A ^a   McDonald, L Clifford ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Bifidobacterium; Dietary supplement; hospital; Lactobacillus; microbial; prevalence; Probiotic; Saccharomyces

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; ANTIVIRUS AGENT; PROBIOTIC AGENT;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGED; ARTICLE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM INFANTIS; BRONCHIECTASIS; CEREBROVASCULAR DISEASE; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; CONGESTIVE HEART FAILURE; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DRUG USE; FEMALE; GRAFT DYSFUNCTION; HEART ARRHYTHMIA; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFANT; INTESTINE INFECTION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LENGTH OF STAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MOOD DISORDER; MULTICENTER STUDY; NEWBORN; OBSERVATIONAL STUDY; OSTEOARTHRITIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREVALENCE; SACCHAROMYCES BOULARDII; SEPTICEMIA; SKIN INFECTION; STREPTOCOCCUS THERMOPHILUS; UNITED STATES; URINARY TRACT INFECTION; VERY ELDERLY; DRUG UTILIZATION; HOSPITAL; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HOSPITALS; HUMANS; INFANT; INPATIENTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROBIOTICS; UNITED STATES; YOUNG ADULT;

EID: 84955572797     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2015.12.001     Document Type: Article

References (30)

1. C. Hill, F. Guarner, G. Reid, G.R. Gibson, D.J. Merenstein, B. Pot, and et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic Nat Rev Gastroenterol Hepatol 11 2014 506 514
2. B. Rodgers, K. Kirley, and A. Mounsey PURLs: prescribing an antibiotic? Pair it with probiotics J Fam Pract 62 2013 148 150
3. K. Brown, K. Valenta, D. Fisman, A. Simor, and N. Daneman Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection JAMA Intern Med 175 2015 626 633
4. S. Hempel, S.J. Newberry, A.R. Maher, Wang Z., J.N. Miles, R. Shanman, and et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis JAMA 307 2012 1959 1969
5. R. Pattani, V.A. Palda, S.W. Hwang, and P.S. Shah Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis Open Med 7 2013 e56 67
6. L.V. McFarland Systematic review and meta-analysis of Saccharomyces boulardii in adult patients World J Gastroenterol 16 2010 2202 2222
7. J.Z. Goldenberg, Ma S., J.D. Saxton, M.R. Martzen, P.O. Vandvik, K. Thorlund, and et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children Cochrane Database Syst Rev 5 2013 CD009329
8. S.J. Allen, K. Wareham, Wang D.L., C. Bradley, H. Hutchings, W. Harris, and et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial Lancet 382 2013 1249 1257
9. V. Venugopalan, K.A. Shriner, and A. Wong-Beringer Regulatory oversight and safety of probiotic use Emerg Infect Dis 16 2010 1661 1665
10. A.M. Abe, P.J. Gregory, D.J. Hein, Z.R. Cochrane, and A.F. Wilson Survey and systematic literature review of probiotics stocked in academic medical centers within the United States Hosp Pharm 48 2013 834 847
11. J. Simkins, A. Kaltsas, and B.P. Currie Investigation of inpatient probiotic use at an academic medical center Int J Infect Dis 17 2013 e321 4
12. Office for Human Research Protections 45 CFR part 46 Protection of Human Subjects http://www.hhs.gov/ohrp/policy/ohrpregulations.pdf Accessed December 30, 2015
13. S. Hempel, S. Newberry, A. Ruelaz, Wang Z., J.N. Miles, M.J. Suttorp, and et al. Safety of probiotics used to reduce risk and prevent or treat disease Evid Rep Technol Assess (Full Rep) 200 2011 1 645
14. S. Fijan Microorganisms with claimed probiotic properties: an overview of recent literature Int J Environ Res Public Health 11 2014 4745 4767
15. W.H. Holzapfel, P. Haberer, R. Geisen, J. Bjorkroth, and U. Schillinger Taxonomy and important features of probiotic microorganisms in food and nutrition Am J Clin Nutr 73 Suppl 2001 365S 373S
16. W.H. Holzapfel, P. Haberer, J. Snel, U. Schillinger, and J.H. Huis in't Veld Overview of gut flora and probiotics Int J Food Microbiol 41 1998 85 101
17. D.L. Cassell The Basics of the PRX Functions Paper presented at: SAS Global Forum April 16-19, 2007 Orlando, FL
18. S. Fridkin, J. Baggs, R. Fagan, and et al. Vital signs: improving antibiotic use among hospitalized patients MMWR Morb Mortal Wkly Rep 63 2014 194 200
19. T.C. Clarke, L.I. Black, B.J. Stussman, P.M. Barnes, and R.L. Nahin Trends in the use of complementary health approaches among adults: United States, 2002-2012 Natl Health Stat Report 79 2015 1 16
20. L.I. Black, T.C. Clarke, P.M. Barnes, B.J. Stussman, and R.L. Nahin Use of complementary health approaches among children aged 4-17 years in the United States: national health interview survey, 2007-2012 Natl Health Stat Report 78 2015 1 19
21. D.A. Freedman Sampling M.S. Lewis-Beck, A. Bryman, Liao T.F. Encyclopedia of Social Science Research Methods Vol. 3 2004 Sage Publications Thousand Oaks (CA) 986 990
22. E.R. Dubberke, P. Carling, R. Carrico, C.J. Donskey, V.G. Loo, L.C. McDonald, and et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update Infect Control Hosp Epidemiol 35 2014 628 645
23. S.H. Cohen, D.N. Gerding, S. Johnson, C.P. Kelly, V.G. Loo, L.C. McDonald, and et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA) Infect Control Hosp Epidemiol 31 2010 431 455
24. C.M. Surawicz, L.J. Brandt, D.G. Binion, A.N. Ananthakrishnan, S.R. Curry, P.H. Gilligan, and et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections Am J Gastroenterol 108 2013 478 498
25. M. Sartelli, M.A. Malangoni, F.M. Abu-Zidan, E.A. Griffiths, S. Di Bella, L.V. McFarland, and et al. WSES guidelines for management of Clostridium difficile infection in surgical patients World J Emerg Surg 10 2015 38
26. K. Whelan, and C.E. Myers Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials Am J Clin Nutr 91 2010 687 703
27. M.G. Besselink, H.C. van Santvoort, E. Buskens, M.A. Boermeester, H. van Goor, H.M. Timmerman, and et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial Lancet 371 2008 651 659
28. P.S. Yeung, M.E. Sanders, C.L. Kitts, R. Cano, and Tong P.S. Species-specific identification of commercial probiotic strains J Dairy Sci 85 2002 1039 1051
29. J. Drisko, B. Bischoff, C. Giles, M. Adelson, Rao R.V., and R. McCallum Evaluation of five probiotic products for label claims by DNA extraction and polymerase chain reaction analysis Dig Dis Sci 50 2005 1113 1117
30. E.J. Goldstein, K.L. Tyrrell, and D.M. Citron Lactobacillus species: taxonomic complexity and controversial susceptibilities Clin Infect Dis 60 Suppl 2015 S98 107